Chat about Fusion Antibodies accounts information. See how Fusion Antibodies is performing financially.

Fusion Antibodies Accounts Summary


Date of Accounts 20262025202420232022
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement30-03-202630-03-202531-03-202430-03-202330-03-2022
Revenue2.111.971.142.904.80
Operating Profit / Loss-1.13-1.63-2.29-2.86-1.32
Net Interest-0.02n/an/an/a-0.01
Pre Tax Profit-1.15-1.63-2.29-2.86-1.33
Post Tax Profit-1.15-1.63-2.23-2.60-1.20
Profit for the Period-1.15-1.63-2.23-2.60-1.20
Equity Holders of Parent Company-1.15-1.63-2.23-2.60-1.20
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-1.20p-1.70p-3.90p-10.00p-4.60p
Earnings per Share (Diluted)-1.20p-1.70p-3.90p-10.00p-4.50p
Earnings per Share (Adjusted)-1.20p-1.70p-3.90p-10.00p-4.60p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-1.20p-1.70p-3.90p-10.00p-4.60p
Earnings per Share (Diluted)-1.20p-1.70p-3.90p-10.00p-4.50p
Earnings per Share (Adjusted)-1.20p-1.70p-3.90p-10.00p-4.60p
      
Dividend per Sharen/apn/apn/apn/apn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet30-03-202630-03-202531-03-202430-03-202330-03-2022
Non-Current Assets     
Intangible Assetsn/an/an/an/an/a
Property, Plant and Equipment0.350.060.160.380.63
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/an/an/an/an/a
Total Non-Current Assets0.350.060.160.380.63
      
Current Assets     
Inventories0.360.270.460.540.58
Trade and Other Receivables0.820.720.560.951.65
Cash at Bank and in Hand1.040.361.200.202.05
Current Asset Investmentsn/an/an/an/an/a
Other Current Assets0.14n/a0.05n/an/a
Total Current Assets2.371.352.261.694.28
      
Other Assetsn/an/an/an/an/a
Total Assets2.731.412.422.064.92
      
Current Liabilities     
Borrowings0.100.020.020.040.07
Other Current Liabilities0.740.600.560.841.14
Total Current Liabilities0.840.620.580.881.21
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings0.23n/a0.020.040.00
Provisions0.03n/a0.020.020.02
Other Non-Current Liabilitiesn/a0.03n/an/an/a
Total Non-Current Liabilities0.260.030.040.060.02
      
Net Assets1.620.761.791.123.68
      
Capital and Reserves     
Share Capital5.004.203.811.041.04
Share Premium Account9.127.947.747.657.65
Other Reservesn/an/an/an/an/a
Retained Earnings-12.50-11.38-9.77-7.56-5.00
Shareholders Funds1.620.761.791.123.68
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity1.620.761.791.123.68
      
 30-03-202630-03-202531-03-202430-03-202330-03-2022
Operating Margin-53.70%-82.85%-201.41%-98.52%-27.61%
Return on Capital Employed-57.11%-209.79%-123.22%-234.65%-35.12%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share1.30p0.60p1.43p0.90p2.94p